Back
Array Technologies Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
32
ARRY
Array Technologies
Last Price:
6.45
Seasonality Move:
-7.01%
Sell
30
ASND
Ascendis Pharma AS
Last Price:
131.97
Seasonality Move:
11.38%
Sell
32
Array Technologies (ARRY)
is a Sell
Is Array Technologies a Buy, Sell or Hold?
- The current Array Technologies [ARRY] share price is $6.48. The Score for ARRY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ARRY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $139.14. The Score for ASND is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARRY Stock Price Chart
What is Array Technologies's stock price today?
-
The Array Technologies share price today is $6.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARRY is experiencing slight selling pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $139.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
ARRY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 45.92 | Sell |
| Chaikin Money Flow: | -1078856 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.2 - 6.84) | Sell |
| Bollinger Bands (100): | (6.79 - 12.13) | Sell |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.85 | Buy |
| Relative Strength Index (14 RSI): | 49.18 | Sell |
| Chaikin Money Flow: | -202245 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (122.38 - 149.98) | Buy |
| Bollinger Bands (100): | (125.51 - 142.39) | Buy |
ARRY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.53 | Sell |
| 20-day SMA: | 6.54 | Sell |
| 50-day SMA: | 7.15 | Sell |
| 200-day SMA: | 11.6 | Sell |
| 8-day EMA: | 6.48 | Sell |
| 20-day EMA: | 6.58 | Sell |
| 50-day EMA: | 7.41 | Sell |
| 200-day EMA: | 11.3 | Sell |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 144.63 | Sell |
| 20-day SMA: | 139.77 | Sell |
| 50-day SMA: | 135.45 | Buy |
| 200-day SMA: | 137.57 | Buy |
| 8-day EMA: | 143.16 | Sell |
| 20-day EMA: | 141.12 | Sell |
| 50-day EMA: | 137.51 | Buy |
| 200-day EMA: | 131.46 | Buy |
Array Technologies Earnings Growth & ARRY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.31 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.61 per share, and an increase next year of $4.34 per share.
Array Technologies Technical Analysis
| Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||